When It Comes To Marijuana And Hemp, If You Believe In One Plant You Need To Believe …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic RegulationCbdHempPolicyCannabinoids Why…
Understanding Hemp and Marijuana as One Botanical Plant
Hemp and marijuana botanical identity is crucial for clinicians to understand the legal and biological distinctions in cannabis. This knowledge informs counseling on product quality and regulatory oversight. Recognizing their botanical identity helps…
FDA’s New Hemp CBD Enforcement Move Is Encouraging, But Congress Still Needs To …
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyHempCBDSafetyIndustry Clinical Summary The FDA's recent enforcement guidance on hemp-derived CBD represents an…
US (NE): Medical Cannabis Commission approves cultivators as manufacturer process remains …
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchIndustry Clinical Summary # Clinical Summary The Nebraska Medical Cannabis Commission's approval of…
Colorado Targets Hemp-Derived Intoxicating Products
Colorado regulators are taking action against producers of hemp-derived intoxicating products. These products, such as delta-8 THC, pose risks due to lack of regulation and standardized safety testing. Clinicians must stay informed to counsel patients…
Texas smokable hemp ban reversed: How THC flower returned to Austin shelves
Texas hemp smokable flower ban has been reversed, allowing THC flower back on Austin shelves. This change impacts legal access and patient treatment options. Regulatory clarity is essential for patient safety and clinical guidance.
India is ‘treasure trove’ of cannabis genetics, but policy will determine development
India cannabis genetics research reveals a vast untapped resource for therapeutic cannabis strains. Policy frameworks will determine how these genetics can be developed for clinical use. This research could expand pharmaceutical options for patients…
US: Proposed rule would create cannabis research facilities in Missouri
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchHemp Why This Matters Missouri's proposed research facilities would enable clinicians to access data…
Current state of hemp and cannabis
The FDA’s still deciding whether cannabis is medicine or Schedule I contraband, while patients quietly self-titrate in states where it’s apparently more legal than aspirin. Clinical evidence moves slower than the regulatory apparatus, which…
Hemp farmers prepare for planting season ahead of impending ban: ‘We are 100% taking a gamble’
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic HempCbdPolicySupply ChainRegulation Why…
